Examines antibody formation against GLP-1 drugs as a possible mechanism for variable drug effectiveness or tolerance.
To maintain a basic antioxidant pool, 100 mg to 200 mg daily is sufficient
When you combine the sympathomimetic stimulation of phentermine with the incretin-mediated heart rate increase from tirzepatide, monitoring becomes absolutely essential
Treatment selection should consider efficacy data alongside patient preferences, tolerability, insurance coverage, and long-term adherence factors
This would mean only around 35,000 people would have access to Wegovy, when tens of thousands more could be eligible. The National Institute for Health and Care Excellence (Nice), which authorised the drug, advised that it should be taken in conjunction with a low-calorie diet and increased physical exercise